Identification of Optical Coherence Tomography-Defined Coronary Plaque Erosion by Preprocedural Computed Tomography Angiography.


Journal

Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524

Informations de publication

Date de publication:
16 05 2023
Historique:
medline: 18 5 2023
pubmed: 15 5 2023
entrez: 15 5 2023
Statut: ppublish

Résumé

Background A previous coronary computed tomography (CT) angiographic study failed to discriminate optical coherence tomography-defined intact fibrous cap culprit lesions (IFC group) from those with ruptured fibrous caps (RFC group) in patients with coronary artery disease. This study aimed to evaluate the diagnostic efficacy of preprocedural coronary CT imaging in identifying subsequently performed optical coherence tomography-defined plaque rupture or erosion at culprit lesions in patients with non-ST-segment-elevation acute myocardial infarction. Methods and Results This study used data from 2 recently published studies that tested the hypothesis that coronary CT angiography (CCTA) before percutaneous coronary intervention may provide diagnostic information on the high-risk atherosclerotic burden in patients with non-ST-segment-elevation acute myocardial infarction. In the analysis of 186 patients, optical coherence tomography identified 106 RFC plaques and 80 IFC plaques as the culprit lesions. On CT, the prevalence of low-attenuation plaque, positive remodeling, napkin-ring sign, and spotty calcification were all significantly lower in the IFC group. The culprit vessel pericoronary adipose tissue inflammation and coronary artery calcium scores were significantly lower in the IFC group than in the RFC group. The absence of low-attenuation plaque, napkin-ring sign, zero coronary artery calcium, and low pericoronary adipose tissue inflammation were independent predictors of IFC. When stratified into 5 subgroups according to the number of these 4 CT factors, the prevalence of IFC was 8.3%, 20.8%, 44.6%, 75.6%, and 100% (

Identifiants

pubmed: 37183866
doi: 10.1161/JAHA.122.029239
pmc: PMC10227319
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e029239

Références

JACC Cardiovasc Imaging. 2013 Mar;6(3):283-7
pubmed: 23473109
J Am Heart Assoc. 2020 Sep;9(17):e016504
pubmed: 32856503
JAMA Cardiol. 2022 Jan 1;7(1):36-44
pubmed: 34705022
J Am Coll Cardiol. 2014 Aug 19;64(7):684-92
pubmed: 25125300
J Am Coll Cardiol. 2018 Jul 24;72(4):434-447
pubmed: 30025580
Eur Heart J. 2021 Apr 7;42(14):1289-1367
pubmed: 32860058
J Am Coll Cardiol. 2021 Mar 2;77(8):1044-1052
pubmed: 33632478
Eur Heart J. 2015 Jun 7;36(22):1377-84
pubmed: 25713314
Circ Cardiovasc Interv. 2017 Dec;10(12):
pubmed: 29246916
Circ Res. 2019 Jan 4;124(1):150-160
pubmed: 30605419
Am J Cardiol. 2020 Nov 1;134:24-31
pubmed: 32892989
J Cardiovasc Comput Tomogr. 2020 Nov - Dec;14(6):483-489
pubmed: 32057707
EuroIntervention. 2020 Aug 28;16(5):395-403
pubmed: 32310132
Am J Med. 2011 Jan;124(1):40-7
pubmed: 21187184
Front Cardiovasc Med. 2022 Jan 31;8:825523
pubmed: 35174226
J Cardiol. 2020 May;75(5):485-493
pubmed: 32085904
Eur Heart J. 2011 May;32(10):1251-9
pubmed: 21273202
Lancet. 2018 Sep 15;392(10151):929-939
pubmed: 30170852
J Am Coll Cardiol. 2012 Mar 20;59(12):1058-72
pubmed: 22421299
Atherosclerosis. 2021 Feb;318:45-51
pubmed: 33127074
N Engl J Med. 1999 Jan 14;340(2):115-26
pubmed: 9887164
Eur Heart J. 2017 Mar 14;38(11):792-800
pubmed: 27578806
Nat Rev Cardiol. 2021 Oct;18(10):724-734
pubmed: 33953381
JACC Cardiovasc Interv. 2018 Oct 22;11(20):2058-2068
pubmed: 30336810
J Cardiovasc Comput Tomogr. 2016 Nov - Dec;10(6):435-449
pubmed: 27780758
Eur Heart J. 2011 Nov;32(22):2814-23
pubmed: 21719455
J Am Coll Cardiol. 2013 Nov 5;62(19):1748-58
pubmed: 23810884
J Am Coll Cardiol. 2020 Feb 11;75(5):453-463
pubmed: 32029126
Circulation. 2016 Mar 1;133(9):849-58
pubmed: 26801055
Eur Heart J. 2018 Jun 7;39(22):2070-2076
pubmed: 29329384
Eur Heart J. 2010 Feb;31(4):401-15
pubmed: 19892716
N Engl J Med. 2000 Mar 23;342(12):836-43
pubmed: 10733371
JACC Cardiovasc Imaging. 2022 May;15(5):828-839
pubmed: 34876381
Heart. 2022 Apr;108(7):500-506
pubmed: 34234006
J Am Coll Cardiol. 2020 Nov 24;76(21):2421-2432
pubmed: 33213720

Auteurs

Tatsuhiro Nagamine (T)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Masahiro Hoshino (M)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Taishi Yonetsu (T)

Department of Interventional Cardiology Tokyo Medical and Dental University Tokyo Japan.

Tomoyo Sugiyama (T)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Yoshihisa Kanaji (Y)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Kazuki Matsuda (K)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Kodai Sayama (K)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Hiroki Ueno (H)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Kai Nogami (K)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Yoshihiro Hanyu (Y)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Toru Misawa (T)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Masahiro Hada (M)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Eisuke Usui (E)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Tetsuo Sasano (T)

Department of Cardiovascular Medicine Tokyo Medical and Dental University Tokyo Japan.

Tsunekazu Kakuta (T)

Division of Cardiovascular Medicine Tsuchiura Kyodo General Hospital Ibaraki Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH